Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Pacira BioSciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 24.06 · gapped above the open, then crossed back over prior close. High/low 24.80 at 6:00 am ET, 23.69 at 12:15 pm ET.
249 institutional managers report a position in Pacira BioSciences, Inc. worth $1.1B between them, filed on form 13F for the quarter ending 2026-06-30. 30 of them hold 80% of it, the largest being BlackRock, Inc. at 15.33%.
224 more managers in the register
30 managers hold 80% of the $1.1B institutional base. The other 219 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
PCRX (Pacira BioSciences, Inc.) has 7 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: TMO −0.14%, in healthcare.
via Doma Perpetual Capital Management LLC, LSV Asset Management, Marshall Wace LLP +3 more · 6.35% of PCRX, 8.32% of INMD
via LSV Asset Management, Wellington Management Group LLP, Bridgeway Capital Management Inc +9 more · 1.39% of PCRX, 4.61% of NTCT
via Doma Perpetual Capital Management LLC, Wellington Management Group LLP, PDT Partners, LLC · 6.35% of PCRX, 22.11% of AFYA
via Doma Perpetual Capital Management LLC, Marshall Wace LLP · 6.35% of PCRX, 7.96% of HIFS
via LSV Asset Management, Wellington Management Group LLP, Bridgeway Capital Management Inc +7 more · 1.39% of PCRX, 4.17% of RM
via LSV Asset Management, Wellington Management Group LLP, Bridgeway Capital Management Inc +7 more · 1.39% of PCRX, 3.90% of UPBD
Managers holding a meaningful stake in PCRX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.